Relmada Therapeutics Inc banner

Relmada Therapeutics Inc
NASDAQ:RLMD

Watchlist Manager
Relmada Therapeutics Inc Logo
Relmada Therapeutics Inc
NASDAQ:RLMD
Watchlist
Price: 4.29 USD -10.06% Market Closed
Market Cap: $314.6m

Wall Street
Price Targets

RLMD Price Targets Summary
Relmada Therapeutics Inc

Wall Street analysts forecast RLMD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for RLMD is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Lowest
Price Target
8.08 USD
88% Upside
Average
Price Target
9.18 USD
114% Upside
Highest
Price Target
10.5 USD
145% Upside
Relmada Therapeutics Inc Competitors:
Price Targets
CXT
Crane NXT Co
91% Upside

Revenue
Forecast

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-61%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is RLMD's stock price target?
Price Target
9.18 USD

According to Wall Street analysts, the average 1-year price target for RLMD is 9.18 USD with a low forecast of 8.08 USD and a high forecast of 10.5 USD.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett